Related Experiment Videos
Malignant melanoma and pregnancy.
1Department of Surgery, Duke University Medical Center, Durham, NC.
Annals of Plastic Surgery
|January 11, 1992
Summary
Pregnancy at melanoma diagnosis is linked to a higher risk of metastasis, but not mortality. Pregnant patients experienced shorter disease-free intervals and more lymph node involvement compared to nonpregnant individuals.
Area of Science:
- Oncology
- Dermatology
- Reproductive Medicine
Background:
- Melanoma during pregnancy presents unique clinical challenges.
- The impact of pregnancy on melanoma progression remains debated in scientific literature.
- Existing research on hormonal influences on melanoma has yielded conflicting results.
Purpose of the Study:
- To investigate the association between pregnancy at the time of melanoma diagnosis and disease progression.
- To compare melanoma outcomes in pregnant versus nonpregnant female patients.
- To determine if pregnancy influences the risk of developing metastatic melanoma.
Main Methods:
- Retrospective cohort study comparing 100 pregnant melanoma patients with a nonpregnant female cohort.
- Follow-up duration averaged 6.8 years.
- Multivariate analysis controlled for tumor characteristics like site, thickness, and Clark level.
Main Results:
- Pregnant patients had significantly shorter median disease-free intervals (5.8 vs. 11.9 years).
- Higher incidence of lymph node metastases observed in pregnant patients (48% vs. 26% at 10 years).
- Pregnancy at diagnosis was significantly associated with metastatic disease development (p=0.008), but not patient mortality.
Conclusions:
- Pregnancy at diagnosis is a significant risk factor for melanoma metastasis.
- While pregnancy is linked to increased metastatic risk, it does not appear to impact melanoma-specific survival.
- Further research is needed to elucidate the mechanisms underlying pregnancy's effect on melanoma progression.